Medpace Holdings, Inc. (MEDP)
Services-Commercial Physical & Biological Research
Latest Price
$577.11
TTM P/E
33.87
Normalized P/E
52.27
Div Yield
--
Book Value
15.33
P/B Ratio
37.65
Valuation metrics
adjust assumptions →EPS: $15.28
Book value / share: $16.18
Formula: √(22.5 × EPS × BVPS)
Graham Number
$74.59
87% downside
Norm. op. income: $279M (median of 7yr)
Tax rate: 15%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$100.99
83% downside
Base FCF: $397M (median of recent 5yr)
Growth: 21%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$817.48
+42% upside
EPS: $15.28
Target P/E: 52×
Formula: EPS × P/E
P/E Fair Value
$794.56
+38% upside
Institutional Ownership
79.1% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2.47M | $1.19B | 8.85% | +57.8K | 2026-03-31 |
| AQR CAPITAL MANAGEMENT LLC | 1.35M | $633.0M | 4.85% | +4.1K | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.12M | $538.0M | 4.02% | -- | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.01M | $485.0M | 3.62% | -- | 2026-03-31 |
| WASATCH ADVISORS LP | 773.9K | $371.0M | 2.77% | +125.6K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 745.1K | $357.0M | 2.67% | +77.8K | 2026-03-31 |
| STATE STREET CORP | 682.2K | $327.0M | 2.44% | +17.3K | 2026-03-31 |
| Invesco Ltd. | 577.6K | $277.0M | 2.07% | +94.9K | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 504.7K | $242.0M | 1.81% | +38.8K | 2026-03-31 |
| BAILLIE GIFFORD & CO | 503.2K | $241.0M | 1.80% | -43.9K | 2026-03-31 |